Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324453 · ClinicalTrials.gov registry record · Phase 1
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
A Phase 1 study, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 103
- Enrollment target
NCT01324453 is a Phase 1 study that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 103 participants.
The verdict
NCT01324453, a Phase 1 study, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 103 participants
- Enrollment target
Study Summary
This study will evaluate change in heart muscle function from baseline to three months and twelve months in participants who present with a heart attack and a completely occluded coronary artery. These subjects will be randomized to receive standard Percutaneous transluminal coronary angioplasty (PTCA)/Stenting to open the artery or routine PTCA/Stenting plus post conditioning. Post conditioning commences immediately upon reperfusion using four cycles of thirty second inflations with a standard angioplasty balloon followed by a thirty seconds of reperfusion. The investigators hypothesize that Postconditioning reduces the size of the heart attack when utilized with successful primary Angioplasty/stent.
Interventions
- PROCEDURE Post Conditioning + Primary PCI
- PROCEDURE Standard Primary PCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324453
The ClinicalTrials.gov registry entry for NCT01324453 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Post Conditioning + Primary PCI is the first listed.
NCT01324453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324453 about?
NCT01324453 is a clinical study titled "Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)". This study will evaluate change in heart muscle function from baseline to three months and twelve months in participants who present with a heart attack and a completely occluded coronary artery. These subjects will be randomized to receive standard Percutaneous transluminal coronary angioplasty (PT...
What is the current status of trial NCT01324453?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 103 participants. The study started on 2011-03. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01324453?
The interventions under investigation include: Post Conditioning + Primary PCI (PROCEDURE), Standard Primary PCI (PROCEDURE).
Who is sponsoring clinical trial NCT01324453?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.